APNHY
Price
$6.07
Change
+$0.09 (+1.51%)
Updated
Aug 28 closing price
Capitalization
2.69B
AVCNF
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
23.84M
Interact to see
Advertisement

APNHY vs AVCNF

Header iconAPNHY vs AVCNF Comparison
Open Charts APNHY vs AVCNFBanner chart's image
Aspen Pharmacare Holdings
Price$6.07
Change+$0.09 (+1.51%)
Volume$183
Capitalization2.69B
Avicanna
Price$0.20
Change-$0.00 (-0.00%)
Volume$159.01K
Capitalization23.84M
APNHY vs AVCNF Comparison Chart in %
Loading...
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVCNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APNHY vs. AVCNF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHY is a Hold and AVCNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (APNHY: $6.07 vs. AVCNF: $0.20)
Brand notoriety: APNHY and AVCNF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: APNHY: 4% vs. AVCNF: 239%
Market capitalization -- APNHY: $2.69B vs. AVCNF: $23.84M
APNHY [@Pharmaceuticals: Generic] is valued at $2.69B. AVCNF’s [@Pharmaceuticals: Generic] market capitalization is $23.84M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHY’s FA Score shows that 1 FA rating(s) are green whileAVCNF’s FA Score has 0 green FA rating(s).

  • APNHY’s FA Score: 1 green, 4 red.
  • AVCNF’s FA Score: 0 green, 5 red.
According to our system of comparison, APNHY is a better buy in the long-term than AVCNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APNHY’s TA Score shows that 4 TA indicator(s) are bullish while AVCNF’s TA Score has 5 bullish TA indicator(s).

  • APNHY’s TA Score: 4 bullish, 6 bearish.
  • AVCNF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AVCNF is a better buy in the short-term than APNHY.

Price Growth

APNHY (@Pharmaceuticals: Generic) experienced а -3.27% price change this week, while AVCNF (@Pharmaceuticals: Generic) price change was +2.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.15%. For the same industry, the average monthly price growth was +68.06%, and the average quarterly price growth was +81.85%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.15% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APNHY($2.69B) has a higher market cap than AVCNF($23.8M). AVCNF YTD gains are higher at: 0.542 vs. APNHY (-26.574). APNHY has higher annual earnings (EBITDA): 8.02B vs. AVCNF (-1.47M). APNHY has more cash in the bank: 6.8B vs. AVCNF (457K). AVCNF has less debt than APNHY: AVCNF (73.5K) vs APNHY (35.5B). APNHY has higher revenues than AVCNF: APNHY (45.5B) vs AVCNF (25.3M).
APNHYAVCNFAPNHY / AVCNF
Capitalization2.69B23.8M11,307%
EBITDA8.02B-1.47M-547,344%
Gain YTD-26.5740.542-4,902%
P/E Ratio10.61N/A-
Revenue45.5B25.3M179,842%
Total Cash6.8B457K1,488,840%
Total Debt35.5B73.5K48,299,320%
FUNDAMENTALS RATINGS
APNHY vs AVCNF: Fundamental Ratings
APNHY
AVCNF
OUTLOOK RATING
1..100
5681
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8863
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APNHY's Valuation (9) in the null industry is somewhat better than the same rating for AVCNF (65). This means that APNHY’s stock grew somewhat faster than AVCNF’s over the last 12 months.

APNHY's Profit vs Risk Rating (100) in the null industry is in the same range as AVCNF (100). This means that APNHY’s stock grew similarly to AVCNF’s over the last 12 months.

APNHY's SMR Rating (100) in the null industry is in the same range as AVCNF (100). This means that APNHY’s stock grew similarly to AVCNF’s over the last 12 months.

AVCNF's Price Growth Rating (63) in the null industry is in the same range as APNHY (88). This means that AVCNF’s stock grew similarly to APNHY’s over the last 12 months.

AVCNF's P/E Growth Rating (100) in the null industry is in the same range as APNHY (100). This means that AVCNF’s stock grew similarly to APNHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APNHYAVCNF
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVCNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPPM0.06N/A
N/A
TMPOS Inc
SDCH0.10N/A
N/A
SideChannel Inc.
VMTHF0.25N/A
N/A
VENUS MEDTECH HANGZHOU INC.
IRRHF2962.74N/A
N/A
Interroll Holdings SA
ALBHF0.66-0.07
-9.84%
Alibaba Health Information Technology Ltd

APNHY and

Correlation & Price change

A.I.dvisor tells us that APNHY and TRUFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APNHY and TRUFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHY
1D Price
Change %
APNHY100%
+1.42%
TRUFF - APNHY
21%
Poorly correlated
-0.28%
PRFX - APNHY
20%
Poorly correlated
-8.70%
ESALF - APNHY
20%
Poorly correlated
N/A
SDZNY - APNHY
20%
Poorly correlated
+0.24%
BIOVF - APNHY
19%
Poorly correlated
N/A
More

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
+3.32%
PRFX - AVCNF
20%
Poorly correlated
-8.70%
ARSUF - AVCNF
12%
Poorly correlated
N/A
BSPK - AVCNF
9%
Poorly correlated
N/A
APNHY - AVCNF
7%
Poorly correlated
+1.42%
BKUH - AVCNF
5%
Poorly correlated
N/A
More